drugset
Drugs / HIVIS DNA
last change Oct 2023 re-read 2 minutes ago

HIVIS DNA

Vaccine

Developed for
HIV infectious disease
Investigated by
Armed Forces Research Institute of Medical Sciences, Thailand · Bambino Gesù Hospital and Research Institute · Case Western Reserve University · Chulalongkorn University · Henry M. Jackson Foundation for the Advancement of Military Medicine · Johns Hopkins University
+6 more · Karolinska Institutet · Leidos Biomedical Research, Inc. · PENTA Foundation · University of Miami · University of Padova · Walter Reed Army Institute of Research (WRAIR)

Trials 1 · a red edge is where a trial was stopped

today NCT04301154 · Ph 1
20222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT04301154 Feb 2022 → Oct 2023 HIV infectious disease Henry M. Jackson Foundation for the Advancement of Military Medicine Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as HIVIS DNA ClinicalTrials.gov intervention name — accepted as the source's own label NCT04301154 ↗
Modality Vaccine “HIVIS DNA and MVA-CMDR vaccines induce immune responses important for clearing infected cells” NCT04301154 ↗
Route Intramuscular “HIVIS DNA IM by needle-free injection at weeks 0 and 4” NCT04301154 ↗